PolyPid Ltd. (PYPD)
Last updated: 2026-10-21 12:31:00. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Summary
PolyPid Ltd. (PYPD) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $5.14, with a market capitalization of $99.12M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $3.10 to $5.73. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$99.12M | |
$5.14 | |
$583.50 | |
$2.30 | |
$5.15 | |
1.00K | |
127.56K | |
-- | |
$5.73 | |
$3.10 | |
-- | |
-- |
PolyPid Ltd. (PYPD) Pre-Market Stock Price
PolyPid Ltd. (PYPD) is trading at $5.14 in pre-market trading as of 2026-10-21 12:18:00, down 0.19% ($0.01) from the previous close of $5.15
Pre-market trading shows how investors are pricing PYPD before the regular session opens. The current pre-market price is near the previous close, indicating cautious early trading sentiment.
PolyPid Ltd. (PYPD) 7-Day Stock Price Change
Over the past seven days, PolyPid Ltd. (PYPD) moved from $5.02 to $5.14, representing a gain of 2.39% ($0.12).
The stock traded between $4.61 and $5.17 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 113.70 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
PYPD 52-Week Price Position
Position in Range: 77.6%
PYPD is currently trading at $5.14, placing it 77.6% of the way from its 52-week low of $3.10 to its 52-week high of $5.73. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is PolyPid Ltd. (PYPD)?
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. The company's product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
PolyPid Ltd. Information
| Employees | 75 |
| Exchange | NASDAQ |
| Company Website |
How to Buy PolyPid Ltd. (PYPD) Stock on MEXC
Eligible investors can buy real shares of PolyPid Ltd. (PYPD) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is PolyPid Ltd. (PYPD) stock price today?
2.Is PYPD stock going up or down today?
3.What is PYPD pre-market price?
4.What is PYPD after-hours price?
5.Is PYPD stock trading now?
6.Where does PYPD sit relative to its 52-week high and low?
7.What sector is PolyPid Ltd. in?
8.What is PolyPid Ltd.'s market capitalization and where is it listed?
9.How is PYPD valued in terms of P/E ratio and EPS?
10.Does PolyPid Ltd. pay a dividend?
Explore More US Stocks
Search Stocks
PYPD Stock Calculator
Estimate the value between PYPD shares and USD.
PYPD Shares to USD
1.00 PYPD shares = 5.14 USD
Calculations are estimates based on the latest available price and are for reference only.


